ReviewBiomedicines2023
Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs.
Dongyu Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewBiomedicines2023
Dongyu Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.